Development and evaluation of a genomic signature for the prediction and mechanistic assessment of nongenotoxic hepatocarcinogens in the rat.
暂无分享,去创建一个
Scott M. Auerbach | M. Fielden | A. Adai | N. Raghavan | J. Aubrecht | E. Boitier | P. Nioi | R. Dunn | J. Sherlock | B. Car | Yi Yang | Shenjue Chen | J. Sina | A. Olaharski | G. Searfoss | D. Jacobson-Kram | A. Kincaid | Nandini Raghavan
[1] Russell S. Thomas,et al. Application of transcriptional benchmark dose values in quantitative cancer and noncancer risk assessment. , 2011, Toxicological sciences : an official journal of the Society of Toxicology.
[2] M. Waters,et al. Characterizing and predicting carcinogenicity and mode of action using conventional and toxicogenomics methods. , 2010, Mutation research.
[3] Pedro Romero,et al. Toxicogenomics and cancer risk assessment: a framework for key event analysis and dose-response assessment for nongenotoxic carcinogens. , 2010, Regulatory toxicology and pharmacology : RTP.
[4] T. Chen,et al. Pravastatin Attenuates Carboplatin-Induced Nephrotoxicity in Rodents via Peroxisome Proliferator-Activated Receptor α-Regulated Heme Oxygenase-1 , 2010, Molecular Pharmacology.
[5] S. Auerbach,et al. Predicting the hepatocarcinogenic potential of alkenylbenzene flavoring agents using toxicogenomics and machine learning. , 2010, Toxicology and applied pharmacology.
[6] S. Cohen. Evaluation of Possible Carcinogenic Risk to Humans Based on Liver Tumors in Rodent Assays , 2010, Toxicologic pathology.
[7] T. Nikolskaya,et al. Use of short-term transcriptional profiles to assess the long-term cancer-related safety of environmental and industrial chemicals. , 2009, Toxicological sciences : an official journal of the Society of Toxicology.
[8] A. Martelli,et al. Update on genotoxicity and carcinogenicity testing of 472 marketed pharmaceuticals. , 2009, Mutation research.
[9] R. Snyder,et al. Prediction of non-genotoxic carcinogenesis in rats using changes in gene expression following acute dosing. , 2008, Chemico-biological interactions.
[10] N. Kiyosawa,et al. A toxicogenomics approach for early assessment of potential non-genotoxic hepatocarcinogenicity of chemicals in rats. , 2008, Toxicology.
[11] M. Fielden,et al. Interlaboratory evaluation of genomic signatures for predicting carcinogenicity in the rat. , 2008, Toxicological sciences : an official journal of the Society of Toxicology.
[12] J. Ward. Value of rodent carcinogenesis bioassays. , 2008, Toxicology and applied pharmacology.
[13] B. Elliott,et al. Review of the in vitro and in vivo genotoxicity of dichlorvos. , 2007, Regulatory toxicology and pharmacology : RTP.
[14] John R. Bucher,et al. Conflicting Views on Chemical Carcinogenesis Arising from the Design and Evaluation of Rodent Carcinogenicity Studies , 2007, Environmental health perspectives.
[15] M. Dominick,et al. Nonclinical Safety Evaluation of Muraglitazar, a Novel PPARα/γ Agonist , 2007 .
[16] M. Fielden,et al. A gene expression biomarker provides early prediction and mechanistic assessment of hepatic tumor induction by nongenotoxic chemicals. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.
[17] Harvey J Clewell,et al. A method to integrate benchmark dose estimates with genomic data to assess the functional effects of chemical exposure. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.
[18] A. Bittner,et al. Predictive toxicogenomics approaches reveal underlying molecular mechanisms of nongenotoxic carcinogenicity , 2006, Molecular carcinogenesis.
[19] A. Jacobs. Prediction of 2-year carcinogenicity study results for pharmaceutical products: how are we doing? , 2005, Toxicological sciences : an official journal of the Society of Toxicology.
[20] Lutz Müller,et al. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I. Sensitivity, specificity and relative predictivity. , 2005, Mutation research.
[21] David Kirkland,et al. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens III. Appropriate follow-up testing in vivo. , 2005, Mutation research.
[22] L. Gold,et al. Supplement to the Carcinogenic Potency Database (CPDB): results of animal bioassays published in the general literature through 1997 and by the National Toxicology Program in 1997-1998. , 2005, Toxicological sciences : an official journal of the Society of Toxicology.
[23] E. Boitier,et al. Characterization of an acute molecular marker of nongenotoxic rodent hepatocarcinogenesis by gene expression profiling in a long term clofibric acid study. , 2005, Chemical research in toxicology.
[24] A. Jacobs,et al. Human carcinogenic risk evaluation, Part III: Assessing cancer hazard and risk in human drug development. , 2004, Toxicological sciences : an official journal of the Society of Toxicology.
[25] Samuel M Cohen,et al. Human carcinogenic risk evaluation: an alternative approach to the two-year rodent bioassay. , 2004, Toxicological sciences : an official journal of the Society of Toxicology.
[26] G Pearse,et al. Prediction of Rodent Carcinogenesis: An Evaluation of Prechronic Liver Lesions as Forecasters of Liver Tumors in NTP Carcinogenicity Studies , 2004, Toxicologic pathology.
[27] R. Maronpot,et al. Relevance of Animal Carcinogenesis Findings to Human Cancer Predictions and Prevention , 2004, Toxicologic pathology.
[28] J. Contrera,et al. Predicting the carcinogenic potential of pharmaceuticals in rodents using molecular structural similarity and E-state indices. , 2003, Regulatory toxicology and pharmacology : RTP.
[29] Tomoyuki Shirai,et al. A medium‐term rat liver bioassay for rapid in vivo detection of carcinogenic potential of chemicals , 2003, Cancer science.
[30] J. Ashby,et al. Prediction of rodent nongenotoxic carcinogenesis: evaluation of biochemical and tissue changes in rodents following exposure to nine nongenotoxic NTP carcinogens. , 2002, Environmental health perspectives.
[31] I. Weissman,et al. The Hox cofactor and proto-oncogene Pbx1 is required for maintenance of definitive hematopoiesis in the fetal liver. , 2001, Blood.
[32] R. T. Bunch,et al. The Syrian Hamster Embryo (SHE) Cell Transformation Assay: Review of the Methods and Results , 2001, Toxicologic pathology.
[33] R. Montero,et al. Genotoxic activity of praziquantel. , 1997, Mutation research.
[34] S Parodi,et al. Nongenotoxic carcinogens: development of detection methods based on mechanisms: a European project. , 1996, Mutation research.
[35] H. Rosenkranz,et al. Learning rules to predict rodent carcinogenicity of non-genotoxic chemicals. , 1995, Mutation research.
[36] A. Monro,et al. Marketed Human Pharmaceuticals Reported to be Tumorigenic in Rodents , 1995 .
[37] J K Haseman,et al. Comparative results of 327 chemical carcinogenicity studies. , 1987, Environmental health perspectives.
[38] M. Tatematsu,et al. Placental Glutathione S-Transferase (GST-P) as a New Marker for Hepatocarcinogenesis: In Vivo Short-Term Screening for Hepatocarcinogens , 1987, Toxicologic pathology.
[39] Juan Riego Sintes,et al. European experience in chemicals management: integrating science into policy. , 2011, Environmental science & technology.
[40] Raffaella Corvi,et al. ECVAM prevalidation of three cell transformation assays. , 2011, ALTEX.
[41] H. Ellinger-Ziegelbauer,et al. Prediction of a carcinogenic potential of rat hepatocarcinogens using toxicogenomics analysis of short-term in vivo studies. , 2008, Mutation research.
[42] M. Dominick,et al. Nonclinical safety evaluation of muraglitazar, a novel PPARalpha/gamma agonist. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.
[43] Heidrun Ellinger-Ziegelbauer,et al. Characteristic expression profiles induced by genotoxic carcinogens in rat liver. , 2004, Toxicological sciences : an official journal of the Society of Toxicology.
[44] G. Williams,et al. Saccharin mechanistic data and risk assessment: urine composition, enhanced cell proliferation, and tumor promotion. , 1996, Pharmacology & therapeutics.
[45] G. Williams,et al. d-limonene mechanistic data and risk assessment: absolute species-specific cytotoxicity, enhanced cell proliferation, and tumor promotion. , 1996, Pharmacology & therapeutics.
[46] J. Brown,et al. Complementarity of genotoxic and nongenotoxic predictors of rodent carcinogenicity. , 1994, Teratogenesis, carcinogenesis, and mutagenesis.
[47] J. Brown,et al. Predicting rodent carcinogenicity of halogenated hydrocarbons by in vivo biochemical parameters. , 1993, Teratogenesis, carcinogenesis, and mutagenesis.